Fingerprint
Dive into the research topics of 'Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically